Bioeconomy Capital

About The Fund

Bioeconomy Capital is an early-stage venture capital (VC) firm based in Seattle, Washington, USA, focusing on driving innovation and transformation across the biological engineering, healthcare, biotechnology, IT, TMT (Technology, Media, Telecom), Energy, CleanTech, AR/VR, and Life Science sectors. As a specialized investor in the bioeconomy, they target enterprises that have the potential to significantly impact how biological systems are harnessed for a wide array of applications. Bioeconomy Capital operates with the belief that advances in biotechnology are essential for solving many global challenges, from healthcare delivery to sustainable energy and materials. The firm engages in Early, Seed, Series A, and Series B rounds of financing, seeking opportunities where they can add significant value beyond capital. Their investment sweet spot is approximately $1,500,000, with a minimum investment threshold of $100,000 and a ceiling of $5,000,000. With assets under management totaling around $50,000,000, Bioeconomy Capital leverages its resources and expertise to shepherd their portfolio companies through critical stages of growth and development. Their approach is tailored to foster innovations that not only lead to commercial success but also create a positive impact on society and the environment, the essence of the bioeconomy revolution. In this aspect, they fill a niche in the venture capital landscape by focusing intensely on companies that align with their thesis around the utilization and enhancement of biological processes and systems.